| Trial Identifier: | 201247 |
| Sponsor: | GlaxoSmithKline |
| Start Date: | June 2017 |
| Primary Completion Date: | July 2020 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Canada, Ontario | Toronto, Ontario, Canada, M5T 3L9 |
| Netherlands | NIJMEGEN, Netherlands, 6525 GA |
| United Kingdom | Birmingham, United Kingdom, B15 2TH |
| United Kingdom | Dundee, United Kingdom, DD1 9SY |
| United Kingdom | Leeds, United Kingdom, LS7 4SA |
| United Kingdom | London, United Kingdom, NW3 2QG |
| United Kingdom, Greater Manchester | Salford, Greater Manchester, United Kingdom, M6 8HD |
| United Kingdom, Merseyside | Liverpool, Merseyside, United Kingdom, L9 7AL |
| United States, California | Los Angeles, California, United States, 90045 |
| United States, California | Stanford, California, United States, 94304 |
| United States, Illinois | Chicago, Illinois, United States, 60611 |
| United States, Maryland | Baltimore, Maryland, United States, 21224 |
| United States, Massachusetts | Boston, Massachusetts, United States, 02118 |
| United States, Michigan | Ann Arbor, Michigan, United States, 48109 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company